Last reviewed · How we verify
Zolpidem - Tablets
At a glance
| Generic name | Zolpidem - Tablets |
|---|---|
| Sponsor | Eli Lilly and Company |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Trial of Zolpidem for Sleep in Children With Autism (PHASE2)
- Efficacy and Safety of APSTZD in the Treatment of Insomnia Disorder (PHASE2)
- Safety and Efficacy Study of YZJ-1139 Tablets in Insomnia Disorder (PHASE3)
- The Study in Outpatient Medicine Using Nudges to Improve Sleep (NA)
- The Effects of Castration on the Pharmacokinetics of Zolpidem After Single Dose Administration In Men With Prostate Cancer Undergoing Androgen Deprivation Therapy Compared to Normal Healthy Females (PHASE1)
- Zolpidem's Effects on Road Cycling Performance (PHASE4)
- Improving Perioperative Sleep Disorders (PHASE1)
- Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1) (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Zolpidem - Tablets CI brief — competitive landscape report
- Zolpidem - Tablets updates RSS · CI watch RSS
- Eli Lilly and Company portfolio CI